Selehold 15 mg spot-on solution for cats and dogs = 2.5 kg

Kraj: Irlandia

Język: angielski

Źródło: HPRA (Health Products Regulatory Authority)

Kup teraz

Pobierz DSU (DSU)
15-09-2023

Składnik aktywny:

Selamectin

Dostępny od:

Krka, d.d., Novo mesto

Kod ATC:

QP54AA05

INN (International Nazwa):

Selamectin

Dawkowanie:

15 mg/pipette

Forma farmaceutyczna:

Spot-on solution

Typ recepty:

POM: Prescription Only Medicine as defined in relevant national legislation

Dziedzina terapeutyczna:

selamectin

Status autoryzacji:

Authorised

Data autoryzacji:

2019-05-17

Charakterystyka produktu

                                1
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Selehold 15 mg spot-on solution for cats and dogs ≤ 2.5 kg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 0.25 ml pipette contains:
ACTIVE SUBSTANCE:
Selamectin
15 mg
EXCIPIENTS:
QUALITATIVE
COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS
QUANTITATIVE
COMPOSITION
IF THAT INFORMATION
IS ESSENTIAL
FOR PROPER ADMINISTRATION OF THE
VETERINARY MEDICINAL PRODUC
t
_ _
Isopropyl alcohol
Butylhydroxytoluene (E321)
0.2 mg
Dimethyl sulfoxide
Clear, colourless to yellow to brown solution.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Cats and dogs (≤ 2.5 kg)
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
CATS AND DOGS:
•
TREATMENT AND PREVENTION OF FLEA INFESTATIONS
caused by
_Ctenocephalides _
spp. for one month
following a single administration. This is as a result of the
adulticidal, larvicidal and ovicidal
properties of the veterinary medicinal product. The veterinary
medicinal product is ovicidal for 3
weeks after administration. Through a reduction in the flea
population, monthly treatment of
pregnant and lactating animals will also aid in the prevention of flea
infestations in the litter up to
seven weeks of age. The veterinary medicinal product can be used as
part of a treatment strategy
for flea allergy dermatitis and through its ovicidal and larvicidal
action may aid in the control of
existing environmental flea infestations in areas to which the animal
has access.
•
PREVENTION OF HEARTWORM DISEASE
caused by
_Dirofilaria immitis _
with monthly administration
•
TREATMENT OF EAR MITES
(
_Otodectes cynotis_
)
CATS:
•
TREATMENT OF BITING LICE INFESTATIONS
(
_Felicola subrostratus_
)
•
TREATMENT OF ADULT ROUNDWORMS
(
_Toxocara cati_
)
•
TREATMENT OF ADULT INTESTINAL HOOKWORMS
(
_Ancylostoma tubaeforme_
)
DOGS:
•
TREATMENT OF BITING LICE INFESTATIONS
(
_Trichodectes canis_
)
2
•
TREATMENT OF SARCOPTIC MANGE
(caused by
_Sarcoptes scabiei_
)
•
TREATMENT OF ADULT INTESTINAL ROUNDWORMS
(
_Toxocara canis_
)
3.3
CONTRAINDICATIONS
Do not use in animals under 6
                                
                                Przeczytaj cały dokument
                                
                            

Wyszukaj powiadomienia związane z tym produktem